Rabies research in Thailand

Asian Biomedicine

Volumn 3, Issue 2, 2009, Pages 213-220

  Garden, Domnern ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Rabies; Research; Thailand

Indexed keywords

PENICILLIN G; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

CLINICAL FEATURE; HAIR FOLLICLE; HEALTH CARE PERSONNEL; HEALTH HAZARD; HISTORY OF MEDICINE; HUMAN; IMMUNOASSAY; LABORATORY TEST; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SOCIETY; NERVOUS TISSUE; NUCLEIC ACID AMPLIFICATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PUBLIC HEALTH SERVICE; RABIES; REVIEW; SURVIVOR; THAILAND; TREATMENT FAILURE; URINALYSIS; WORLD HEALTH ORGANIZATION; ZOONOSIS;

EID: 70349311786     PISSN: 19057415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Vejjajiva A. Neurological Sequelae of Anti-rabies inoculation. J Med Assoc Thai. 1967; 50: 806-813.
2. Thongcharoen P. The Probelm of Rabies Control in Thailand. J Med Assoc Thai. 1973;56:296-300
3. Yasmuth C, Roberts EC antibody in healthy dogs and and vaccine response after MPA. J Med Assoc Thai. 1974; 57:131-134
4. Fekadu M, Shaddock JH, Baer GM. Intermittend excretion of rabies virus in the saliva of a dog two and six month after it had recovered from experimental rabies. Am J Trop Med Hyg. 1981; 30: 1113-1115
5. Yasmuth C, Nelson KE, Laima T, Supawadee J, Thanyanant P. Prevalence of abortive canine rabies in Chiang Mai, Thailand. J Med Assoc Thai. 1983; 66: 169-175
6. Suntharasamai P, Viravan C, Sinhaseni A, Udomsakdi D, et al. An economical regimen of human diploid cell strain anti-rabies vaccine for post exposureprophylaxis. Lancet. 1983; 2:301-304
7. Phanuphak P, Khawplod P, Sirivichayakul W, Ubol S.Thaweepathomwat M. Humoral and cellmediated immune response to various economical regimens of purified vero cell rabies vaccine. Asian Pecific J Allergy Immunol. 1987; 5:33-37
8. Laothamatas J, Wacharapluesadee S, Lumlertdacha B, Ampawong S, Tepsumethanon V, Shuangshoti S, et al. Furious and paralytic rabies of canine origin: neuroimmaging with virological and cytokine studies; J Neurovirol. 2008; 2:119-129
9. Wacharapluesadee S, Hemachudha T. Urine samples for rabies RNA detection in the diagnosis of rabies in humans. Clin Infect Dis. 2002; 15:874-875
10. Wacharapluesadee S, Hemachudha T. Nucleic-acid sequence based amplification in the rapid diagnosis of rabies. Lancet. 2001; 358:892-893
11. Wacharapluesadee S, Phumesin P, Lumlertdaecha B, Hemachudha T. Dried brain spot as a method has been developed to conserve viral RNA in brain tissue for at least 222 days, negating the use of a deep freezer. Clin Infect Dis. 2003; 36:674-675
12. Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol. 2002; 1:101-109
13. Laothamatas J, Hemachudha T, Mitrabhakdi E, Wannakrairot P, Tulayadaechanont S. MR imaging in human rabies. Am J Neuroradiol. 2003; 24:1102-1109
14. Denduangboripant J, Wacharapluesadee S, Lumlertdacha B, Ruankaew N, Hoonsuwan W, Puanghat A, Hemachudha T. Transmission dynamics of rabies virus in Thailand: implications for disease control. BMC Infect Dis. 2005; 5:52.
15. Windiyaningsih C, Wilde H, Meslin FX, Suroso T, Widarso HS. The rabies epidemic on Flores Island, Indonesia (1998-2003). J Med Assoc Thai. 2004; 87: 1398-2003.
16. Wacharapluesadee S. Virol Methods. 2008 (in press).
17. Lumlertdacha B, Boongird K, Wanghongsa S, Wacharapluesadee S, Chanhome L, Khawplod P, Hemachudha T, Kuzmin I, Rupprecht CE. Survey for bat lyssaviruses, Thailand. Emerg Infect Dis. 2005; 11: 232-236
18. Wilde H. Failures of post-exposure rabiesprophylaxis. Vaccine. 2007; 25:7605-7609
19. Hemachudha T, Sunsaneewitayakul B, Desudchit T, Suankratay C, Sittipunt C, Wacharapluesadee S, Khawplod P, Wilde H, Jackson AC. Failure of therapeuticcoma and ketamine for therapy of human rabies J Neurovirol. 2006; 12:407-409
20. Wilde H, Hemachudha T, Jackson AC. Viewpoint: Management of human rabies. Trans R Soc Trop Med Hyg. 2008; 102: 979-82.
21. Current Neurology and Neuroscience Reports. 2006; 6:460-468
22. Selimov M, Boltucij L, Selimva E. Anwendung des antirabies Gammaglobulins bei Menschen. J Hyg Epidemiol Microbiol Immunolog. 1959; 3:168-180
23. Dean DJ, Baer GM, Thompson WR. Studies on the local treatment of rabies-infected wounds. Bull World Health Organ. 1963; 28:477-486
24. Saesow N, Chaiwatanarat T, Mitmoonpitak C, Wilde H. Diffusion and fate of intramuscularly injected human rabies immune globulin. Acta Trop. 2000; 76:289-292
25. Wilde H, Thipkong P, Sitprija V , Chaiyabutr N. Hete rologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis. Ann Intern Med. 1996; 125:233-236
26. Khawplod P, Wilde H, Chomchey P, Benjavongkulchai M, Yenmuang W, Chaiyabutr N, Sitprija V. What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously? Vaccine. 1996; 14:389-391
27. Suwansrinon K, Jaijaroensup W, Wilde H, Sitprija V. Is injecting a finger with rabies immunoglobulin dangerous? Am J Trop Med Hyg. 2006; 75:363-364
28. Wilde H, Chutivongse S. Equine rabies immune globulin: a product with an undeserved poor reputation. Am J Trop Med Hyg. 1990; 42:175-178
29. Wilde H, Chomchey P, Prakongsri S, Puyaratabandhu P, Chutivongse S. Adverse effects of equine rabies immune gobulin. Vaccine. 1989; 7:10-11
30. Wilde H, Chomchey P, Punyaratabandhu P, Phanupak P, Chutivongse S. Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin. Bull World Health. Organ.1989; 67:731-736
31. Suwansrinon K, Wilde H, Benjavongkulchai M, Banjongkasaena U, Lertjarutorn S, Boonchang S, Suttisri R, Khowplod P, Daviratanasilpa S, Sitprija V. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity.Vaccine 2006; 24:3878-3880
32. Khawplod P, Wilde H, Sirikwin S, Benjawongkulchai M, Limusanno S, Jaijaroensab W, Chiraguna N, Supich C, Wangroongsarb Y, Sitprija V.Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine. 2006; 24: 3084-3086
33. Tepsumethanon V, Wilde H, Hemachudha T. Intratesticular injection of a balanced zinc solution for permanent sterilization of dogs. J Med Assoc Thai. 2005; 88:686-689
34. Windiyaningsih C, Wilde H, Meslin FX, Suroso T, Widarso HS. The rabies epidemic on Flores Island, Indonesia (1998-2003). J Med Assoc Thai. 2004; 87: 1389-1393
35. Tepsumethanon V, Lumlertdacha B,Mitmoonpitak C, Sitprija V, Meslin FX, Wilde H. Survival of naturally infected rabid dogs and cats. Clin Infect Dis. 2004; 39:281-283
36. Khawplod P, Wilde H, Tepsumethanon S, Limusanno-S, Tantawichien T, Chomchey P, Ayuthaya AB, Wangroonsarb Y. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin. Clin Infect Dis. 2002; 35: 1562-1565
37. Khawplod P, Tantawichien T, Wilde H, Limusanno S, Tantawichien T, Saikasem A, Raksakate S. Use of rabies vaccines after reconstitution and storage. Clin Infect Dis. 2002; 34:404-406
38. Thisyakorn U, Pancharoen C, Wilde H. Immunologic and virologic evaluation of HIV-1-infected children after rabies vaccination. Vaccine. 2001; 19:1534-1537
39. Ananymous. Pall corporation technology helps Thai Red Cross reduce shortages of equine antirabies immunoglobulins. Drug Discovery on Line. 2004; January 7.
40. Suwansrinon K, Jaijaroensup W, Daviratanasilpa C, Sriaroon C, Wilde H. Adverse reactions to human rabies immune geobulin manufactured by the Thai Red Cross Society. Vaccine. 2005; 23: 1324-1325